These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16977780)

  • 1. [Myopathy associated with respiratory insufficiency: diagnostic difficulties in adult-onset Pompe disease].
    Merkli H; Pál E; Nagy F; Horváth R; Várdi VK; Komoly S; Illés Z
    Orv Hetil; 2006 Jul; 147(30):1421-4. PubMed ID: 16977780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myopathy caused by acid maltase deficiency in an adult].
    Cartier L; Cea JG; Slachevsky A
    Rev Med Chil; 1995 Jun; 123(6):758-61. PubMed ID: 8525231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset acid maltase deficiency in a Chinese girl.
    Wong KS; Lai C; Ng HK
    Clin Exp Neurol; 1991; 28():210-8. PubMed ID: 1821829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid maltase deficiency in childhood. Early diagnosis and clinical follow-up of late-onset glycogen storage disease type II.
    di Fiore MT; Manfredi R; Marri L; Zucchini A; Azzaroli L; Manfredi G
    Acta Neurol (Napoli); 1993 Aug; 15(4):258-67. PubMed ID: 8249669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
    Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
    Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome.
    Kostera-Pruszczyk A; Opuchlik A; Lugowska A; Nadaj A; Bojakowski J; Tylki-Szymanska A; Kaminska A
    Neuromuscul Disord; 2006 Apr; 16(4):282-5. PubMed ID: 16531044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid maltase deficiency in adults. A study of five cases.
    Lenders MB; Martin JJ; de Barsy T; Ceuterick C; Marchau M
    Acta Neurol Belg; 1986; 86(3):152-60. PubMed ID: 3090848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype.
    Anneser JM; Pongratz DE; Podskarbi T; Shin YS; Schoser BG
    Neurology; 2005 Jan; 64(2):368-70. PubMed ID: 15668445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
    van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
    Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult form of Pompe disease].
    Ziółkowska-Graca B; Kania A; Zwolińska G; Nizankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2008; 76(5):396-9. PubMed ID: 19003770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rigid spine syndrome revealing late-onset Pompe disease.
    Laforêt P; Doppler V; Caillaud C; Laloui K; Claeys KG; Richard P; Ferreiro A; Eymard B
    Neuromuscul Disord; 2010 Feb; 20(2):128-30. PubMed ID: 20005713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
    Katzin LW; Amato AA
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respiratory failure due to acid maltase deficiency].
    Perez T; Marié E; Lacour A; Maurage CA; Wallaert B
    Rev Mal Respir; 2012 Jan; 29(1):74-8. PubMed ID: 22240224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
    Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
    Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis in anorexia nervosa: glycogenosis II (the Pompe type)].
    Fischer P; Eich W; Haass M; Herzog W
    Dtsch Med Wochenschr; 1999 Aug; 124(31-32):925-9. PubMed ID: 10480012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy for infantile-onset pompe disease: curse or cure?
    Willems J; Petros A; Brierley J
    Neurology; 2008 Jul; 71(5):380-1. PubMed ID: 18663187
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.
    Hagemans ML; Winkel LP; Van Doorn PA; Hop WJ; Loonen MC; Reuser AJ; Van der Ploeg AT
    Brain; 2005 Mar; 128(Pt 3):671-7. PubMed ID: 15659425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pompe disease: a neuromuscular disease with respiratory muscle involvement.
    Mellies U; Lofaso F
    Respir Med; 2009 Apr; 103(4):477-84. PubMed ID: 19131232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.